New PET scan for early pancreatic cancer detection
Part of Cancer clinical trials.
This trial tests a new type of PET scan that uses a special tracer (FAPI) to get clearer images of pancreatic cancer. The goal is to find cancer earlier and better plan surgery or treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of pancreatic ductal adenocarcinoma (a certain type of pancreatic cancer) confirmed by a biopsy.
- The cancer must not have spread beyond the pancreas, based on a recent CT scan or MRI (within the last month).
- You must also be taking part in another research study called HoMING (or be willing to join it).
- You must be 18 years or older and have health insurance (or social security coverage).
- You must be able to give your permission to take part (informed consent).
- If you can become pregnant, you must use a highly effective birth control method during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of PET scan that uses a radioactive tracer called FAPI-74 to find cancer spread in people with pancreatic cancer. The goal is to see if this scan can help doctors better plan treatment.
This trial uses a special PET scan (68Ga-FAPI-46) to help see pancreatic cancer more clearly before surgery. The goal is to see if this new scan can find cancer that standard scans might miss, helping surgeons plan the best operation.
This trial tests a special imaging scan (a PET/CT with a tracer called 68Ga-FAPI-46) to look at “cancer-support” cells in people with localized pancreatic ductal adenocarcinoma. It may help doctors better understand the tumor and how it responds before surgery after initial treatment.
This study tests a new type of PET scan (a detailed imaging test) called [68Ga]Ga-FAPI that may help doctors see cancer better and faster than standard scans. You'll receive this experimental scan to see if it improves cancer detection before surgery.
This trial tests a new imaging method called FAPI-PET to see if it can better detect pancreatic and bile duct cancers at an early stage. It may help doctors decide on the best treatment plan for you.
This trial uses a special PET scan (FAPi PET) to see if it can help spot pancreatic ductal adenocarcinoma better than standard scans. It may offer a more precise way to check the extent of the disease.
Hear when a new Pancreatic Ductal Adenocarcinoma (PDAC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.